Baraitser-Winter cerebrofrontofacial syndrome: delineation of the spectrum in 42 cases
Carregando...
Citações na Scopus
101
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
NATURE PUBLISHING GROUP
Autores
VERLOES, Alain
DONATO, Nataliya Di
MASLIAH-PLANCHON, Julien
JONGMANS, Marjolijn
ABDUL-RAMAN, Omar A.
ALBRECHT, Beate
ALLANSON, Judith
BRUNNER, Han
CHASSAING, Nicolas
Citação
EUROPEAN JOURNAL OF HUMAN GENETICS, v.23, n.3, p.292-301, 2015
Resumo
Baraitser-Winter, Fryns-Aftimos and cerebrofrontofacial syndrome types 1 and 3 have recently been associated with heterozygous gain-of-function mutations in one of the two ubiquitous cytoplasmic actin-encoding genes ACTB and ACTG1 that encode beta-and gamma-actins. We present detailed phenotypic descriptions and neuroimaging on 36 patients analyzed by our group and six cases from the literature with a molecularly proven actinopathy (9 ACTG1 and 33 ACTB). The major clinical anomalies are striking dysmorphic facial features with hypertelorism, broad nose with large tip and prominent root, congenital non-myopathic ptosis, ridged metopic suture and arched eyebrows. Iris or retinal coloboma is present in many cases, as is sensorineural deafness. Cleft lip and palate, hallux duplex, congenital heart defects and renal tract anomalies are seen in some cases. Microcephaly may develop with time. Nearly all patients with ACTG1 mutations, and around 60% of those with ACTB mutations have some degree of pachygyria with anteroposterior severity gradient, rarely lissencephaly or neuronal heterotopia. Reduction of shoulder girdle muscle bulk and progressive joint stiffness is common. Early muscular involvement, occasionally with congenital arthrogryposis, may be present. Progressive, severe dystonia was seen in one family. Intellectual disability and epilepsy are variable in severity and largely correlate with CNS anomalies. One patient developed acute lymphocytic leukemia, and another a cutaneous lymphoma, indicating that actinopathies may be cancer-predisposing disorders. Considering the multifaceted role of actins in cell physiology, we hypothesize that some clinical manifestations may be partially mutation specific. Baraitser-Winter cerebrofrontofacial syndrome is our suggested designation for this clinical entity.
Palavras-chave
Referências
- BARAITSER M, 1988, J MED GENET, V25, P41, DOI 10.1136/jmg.25.1.41
- Bassell GJ, 1998, J NEUROSCI, V18, P251
- Batista FD, 2010, IMMUNOL REV, V237, P191, DOI 10.1111/j.1600-065X.2010.00943.x
- Bergeron SE, 2010, J BIOL CHEM, V285, P16087, DOI 10.1074/jbc.M110.110130
- Bitton Natalie, 2012, Pediatr Dent, V34, P144
- Bryan KE, 2009, J BIOL CHEM, V284, P18260, DOI 10.1074/jbc.M109.015818
- Bulinski JC, 2006, SCIENCE, V313, P180, DOI 10.1126/science.1130813
- Bunnell TM, 2011, MOL BIOL CELL, V22, P4047, DOI 10.1091/mbc.E11-06-0582
- Der Kaloustian VM, 2001, CLIN DYSMORPHOL, V10, P87, DOI 10.1097/00019605-200104000-00003
- Di Donato N, 2013, EUR J HUM GENET, V22, P179
- Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970
- Fryns JP, 2000, J MED GENET, V37, P460, DOI 10.1136/jmg.37.6.460
- Fryns JP, 1996, AM J MED GENET, V64, P521, DOI 10.1002/ajmg.1320640302
- Ganesh A, 2005, J AAPOS, V9, P604, DOI 10.1016/j.jaapos.2005.05.001
- Gearing M, 2002, ANN NEUROL, V52, P465, DOI 10.1002/ana.10319
- Guion-Almeida ML, 2001, CLIN DYSMORPHOL, V10, P81, DOI 10.1097/00019605-200104000-00002
- GUIONALMEIDA ML, 1992, AM J MED GENET, V43, P938, DOI 10.1002/ajmg.1320430606
- Guo CM, 2013, CLIN CHIM ACTA, V417, P39, DOI 10.1016/j.cca.2012.12.012
- HILL MA, 1993, J CELL BIOL, V122, P825, DOI 10.1083/jcb.122.4.825
- Johnston JJ, 2013, HUM MUTAT, V34, P1242, DOI 10.1002/humu.22350
- Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344
- Khaitlina SY, 2001, INT REV CYTOL, V202, P35, DOI 10.1016/S0074-7696(01)02003-4
- Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139
- Kocak Eker H, 2013, EUR J MED GENET, V57, P32
- Lloyd CM, 2004, EXP CELL RES, V297, P82, DOI 10.1016/j.yexcr.2004.02.012
- Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109
- Machado-Paula LA, 2003, AM J MED GENET A, V117A, P181, DOI 10.1002/ajmg.a.10919
- Milunsky JM, 2003, CLIN GENET, V63, P1
- Miyamoto K, 2013, CELL MOL LIFE SCI, V70, P3289, DOI 10.1007/s00018-012-1235-7
- Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249
- Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646
- Nunoi H, 1999, P NATL ACAD SCI USA, V96, P8693, DOI 10.1073/pnas.96.15.8693
- Oike T, 2013, JPN J CLIN ONCOL, V43, P849, DOI 10.1093/jjco/hyt101
- PALLOTTA R, 1991, J MED GENET, V28, P342, DOI 10.1136/jmg.28.5.342
- PASHAYAN H, 1973, AM J DIS CHILD, V125, P389
- Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862
- Procaccio V, 2006, AM J HUM GENET, V78, P947, DOI 10.1086/504271
- PUTTERMA.AM, 1973, AM J OPHTHALMOL, V76, P825
- Ramer JC, 1992, DYSMORPH CLIN GENET, V6, P15
- RAMER JC, 1995, AM J MED GENET, V57, P403, DOI 10.1002/ajmg.1320570308
- Riviere JB, 2012, NAT GENET, V44, pS441
- Rossi M, 2003, NEUROPEDIATRICS, V34, P287
- Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209
- Sachdev M, 2013, OPHTHALMIC GENET, V34, P65, DOI 10.3109/13816810.2012.695423
- Schaap C, 1992, Genet Couns, V3, P209
- Schoenenberger CA, 2011, EUR J CELL BIOL, V90, P797, DOI 10.1016/j.ejcb.2011.05.002
- Shiihara T, 2010, BRAIN DEV-JPN, V32, P502, DOI 10.1016/j.braindev.2009.04.015
- Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001
- Tondeleir D, 2009, CELL MOTIL CYTOSKEL, V66, P798, DOI 10.1002/cm.20350
- VERLOES A, 1993, J MED GENET, V30, P425, DOI 10.1136/jmg.30.5.425
- Winter RM, 2001, CLIN DYSMORPHOL, V10, P79, DOI 10.1097/00019605-200104000-00001